02197.HK
Clover Biopharmaceuticals, Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 2.12
+7.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.74x
- PEG TTM
- —
- Price / book
- -2.85x
- Price / sales
- 5389.90x
- Price / cash flow
- -28.65x
Enterprise value
- Enterprise value
- HKD 2.5B
- EV / sales
- 5147.35x
- EV / EBITDA
- -8.87x
- EV / EBIT
- -7.93x
- Market cap
- HKD 2.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026